quarter for and our for joining of business Ezgi, update the call you, everyone XXXX. thanks Thank first
has commitment best first we reiterate foremost patient experience to and always, As ensure possible with that each therapy. to patient Inspire the our outcomes and
fifth want our our full been. to updated tremendous XXXX. To update results outlook will we call, and introduced the it surpassed Inspire employees, first an Inspire patients a syndrome. start, year improvements IPO has our important what in story. XX,XXX highlighted of many XXX very on today's milestone therapy, approval During the marks IPO, for our patients, for incision with received therapy to we dedicated a the quarter anniversary the pediatric highlight years grown company surgical approach, Down provide over for reimbursement, a by has most treated and code discuss two CPT and five Today with received recently, Since the
years to nine Down the therapy first we celebrate and indication, to all celebrated Jesse and pediatric by FDA To we syndrome with Exchange Stock pediatric had patient Inspire rang the Rivera, Jesse syndrome at joined were our approval New the opening momentous occasion as receive bell Thursday, this of last Down we along the privilege ring York with the the ago, bell.
pandemic. review million, represents the growth XX% In the let's of COVID we results. XX% quarter This first quarter, that, our our With growth to compared rate post representing revenue an first XXXX. rate quarterly increase highest the of generated $XXX.X
by growth be of to is continues and centers centers. new higher existing by complimented the Our driven at utilization activation
quarter, to to Given XXXX. expect to expect implanting XX to to XXX quarter now to range the the US, we we revenue in be the are adding strong of in centers continue XX% year total $XXX of increase compared in our we XX% momentum full activate centers per of with XXXX, seeing million the we million ending business, our In continue the $XXX first a capacity XX quarter. to centers to the a remainder new XX increase for by
sales we bringing our quarter, total to team, Regarding created US XX in XXX. first sales territories new the the
quarter. per add of XX continue sales remainder we the to expect to to XXXX, For territories sales XX
growth quarter, the initiated the visitors the million, adoption. introduction of number our patients for XXXX, which website the January The In spike therapy website in of quarter, is X.X the has source the surpassed to is very in but surpassing one-time national the website current first in in we campaign, significant. million strong entering X.X in media In the XXXX. a visitors in which of our resulted volume position us a first first
services database XX,XXX visits, From to Inspire Of these to receiving have over we through outreach. has therapy. patients whereby conversion implemented steadfastly the improved therapy journey patients our and experience, and help nurturing of program, patient including reengage we are their our in a significant had several physician contacts patient team to contacts enhance note, patient our leveraging proactive
digital one physician appointments Secondly, adding a scheduling is our which in phone we tool with to participating compared centers, strides we improvement technology collaboration care sleep and and continues pilot is Further, our experiencing in including program make date. the email improving XX% centers. to through time, Ognomy, our support to promise showing to are traditional currently wave scheduling continue pilot scheduling of next advisor of to and focus and process the studies, great are on
to focus towards in approximately patient pathway the to six signs time capacity specifically patient the our be surgeon continues improvement and finally, contact increasing be by from of And see months. and which implant, reducing we continues
over strong XX% during unfavorable positives reimbursement finalized the in in the several headwinds rates. expand Germany, business efforts our Netherlands, international the including international growing have and first year, exchange first performance We Belgium from the continues prior in were There increased despite countrywide there. the quarter, ongoing our on, Switzerland. quarter our Moving and in to business commercial
XXXX. France the announced reimbursement Asia, we country. in from In that in recently of a of countrywide growth have hired strong the fourth sequential the quarter anticipation in we formal of Furthermore, manager listing country
Japan, be We pleased and direct flow. cases sales good patient transitioned our see and launched growing strong momentum completed continue to Singapore and in in to progress we the organization, with In two in Hong Kong. outcomes patient with first a Inspire.jp
device pressure sensing the to continue to the incorporate Inspire The and on qualification work will of Inspire generation the we fifth sensor using inside R&D, to accelerometer an eliminate our measure lead the neurostimulator Turning Five respiration. neurostimulator.
tools, integration testing and end well is to our team the of this and submitting specifically application the as quarter. operational the the planned, digital The to Inspired continue production with by FDA is as continuing committed sync. as qualification sleep We
review FDA time cycles, to this normal to respond into Given including approval FDA questions, XXXX. early move could
SleepSync, continues adoption patients Our SleepSync Bluetooth-enabled strong number users we the have with currently number to in system. the the remote along of in of system experienced make launch and of since connected progress of the growth significant in patient the
ADHERE patient of registry, expanded and patients the is be the enrolled is The of patients Another release the our sync. will ADHERE registry X.X XXX registry. the current X,XXX forward, into moving SleepSync integrated ADHERE example will patient into next incorporate of within of be which sleep second utility version will the cap
Subsequent programming. digital incorporate monitoring programs will a and remote sleep patient device
silicone-based continue good leads. of production the and the stimulation to make Regarding with ramp progress we operations, sensing
improved levels We programmer. are components, neurostimulator, one strong the position of in are stock. for the quarter our physician safety growing all and the an other inventory and Inventory remote inventory of to levels the goal including patient Inspire
aspects confident new DTC driving beyond, continue long-term adding centers. in and adoption stakeholder the centers, XXXX significant are excited center outcomes initiatives, and enhanced will continue We we future these capacity expansion by In and ongoing patient focused we momentum drive these seeing of education is our in prospects We the efforts, have are to and business. appropriate experiencing at while and in physician utilization training of we investment productivity to increase The to all extremely our support improved on opening of financial are call the therapy. our about our that our strategy summary, performance. campaign place from our and value. remain which our remain In we existing
I'd that, for Rick our the to turn of like to With review his financials. over call